HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jennifer Embury Selected Research

5- ((4- (6- chlorothieno(2,3- d)pyrimidin- 4- ylamino)piperidin- 1- yl)methyl)- 2- fluorobenzonitrile

8/2010PRX-08066, a novel 5-hydroxytryptamine receptor 2B antagonist, reduces monocrotaline-induced pulmonary arterial hypertension and right ventricular hypertrophy in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jennifer Embury Research Topics

Disease

1Pulmonary Arterial Hypertension
08/2010
1Body Weight (Weight, Body)
08/2010
1Hypertrophy
08/2010
1Right Ventricular Hypertrophy
08/2010

Drug/Important Bio-Agent (IBA)

15- ((4- (6- chlorothieno(2,3- d)pyrimidin- 4- ylamino)piperidin- 1- yl)methyl)- 2- fluorobenzonitrileIBA
08/2010
1Serotonin ReceptorsIBA
08/2010
1MonocrotalineIBA
08/2010

Therapy/Procedure

1Therapeutics
08/2010